4//SEC Filing
Ahrens Brenton Karl 4
Accession 0001209191-22-062873
CIK 0001659323other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 9:00 PM ET
Size
5.5 KB
Accession
0001209191-22-062873
Insider Transaction Report
Form 4
Ahrens Brenton Karl
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-12-23$0.81/sh+29,125$23,591→ 29,125 totalExercise: $0.81Exp: 2032-12-22→ Ordinary Shares (29,125 underlying)
Footnotes (1)
- [F1]Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on October 1, 2023.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001322927
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 9:00 PM ET
- Size
- 5.5 KB